Vimarsana
Biggest News Aggregation in the World

Page 40 - Listing Rules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Listing Rules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Listing Rules Today - Breaking & Trending Today

Scottish American Investment P L C : Special Business passed at AGM -April 05, 2024 at 06:16 am EDT - Vimarsana News

Scottish American Investment P L C : Special Business passed at AGM -April 05, 2024 at 06:16 am EDT

DocuSign Envelope ID: BEFB3EAD-1330-4453-8DC2-5C9E86FDFB50 Company No: SC000489 THE SCOTTISH AMERICAN INVESTMENT COMPANY P.L.C. ...

CAB Payments : Notice of 2024 Annual General Meeting -April 05, 2024 at 07:32 am EDT - Vimarsana News

CAB Payments : Notice of 2024 Annual General Meeting -April 05, 2024 at 07:32 am EDT

Notice of 2024 AGM 01 ...

Check Cap : AMENDED NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K -April 05, 2024 at 06:05 am EDT - Vimarsana News

Check Cap : AMENDED NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K -April 05, 2024 at 06:05 am EDT

AMENDED NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: On March 20, 2024, Check-Cap Ltd. announced an Extraordinary General Meeting...

Argo Blockchain : March Operational Update - Form 6-K -April 05, 2024 at 06:58 am EDT - Vimarsana News

Argo Blockchain : March Operational Update - Form 6-K -April 05, 2024 at 06:58 am EDT

A4139j UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 6-K ...

ObsEva Announces Delisting from SIX Swiss Exchange and Exemption from Certain Obligations Associated with the Maintenance of Listin - Vimarsana News

ObsEva Announces Delisting from SIX Swiss Exchange and Exemption from Certain Obligations Associated with the Maintenance of Listin

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – April 3, 2024 – ObsEva SA , a biopharmaceutical company developing and commercializing novel therapies...